Bank of Montreal’s GenMark Diagnostics, Inc GNMK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-11,909
| Closed | -$285K | – | 5510 |
|
|
2021
Q1 | $285K | Sell |
11,909
-8,196
| -41% | -$152K | ﹤0.01% | 2949 |
|
|
2020
Q4 | $312K | Buy |
20,105
+8,415
| +72% | +$112K | ﹤0.01% | 2972 |
|
|
2020
Q3 | $166K | Sell |
11,690
-612
| -5% | -$9.35K | ﹤0.01% | 2817 |
|
|
2020
Q2 | $230K | Buy |
12,302
+10,202
| +486% | +$104K | ﹤0.01% | 2660 |
|
|
2020
Q1 | $9K | Sell |
2,100
-8,139
| -79% | -$38.2K | ﹤0.01% | 3541 |
|
|
2019
Q4 | $49K | Buy |
10,239
+2,333
| +30% | +$12.9K | ﹤0.01% | 3854 |
|
|
2019
Q3 | $48K | Buy |
7,906
+219
| +3% | +$1.37K | ﹤0.01% | 3647 |
|
|
2019
Q2 | $50K | Buy |
7,687
+4,554
| +145% | +$32.1K | ﹤0.01% | 3696 |
|
|
2019
Q1 | $22K | Sell |
3,133
-720
| -19% | -$4.74K | ﹤0.01% | 3651 |
|
|
2018
Q4 | $18K | Buy |
3,853
+363
| +10% | +$1.89K | ﹤0.01% | 3692 |
|
|
2018
Q3 | $26K | Sell |
3,490
-11
| -0.3% | -$81 | ﹤0.01% | 3627 |
|
|
2018
Q2 | $22K | Buy |
3,501
+368
| +12% | +$2.43K | ﹤0.01% | 3717 |
|
|
2018
Q1 | $17K | Buy |
+3,133
| New | +$15.6K | ﹤0.01% | 3614 |
|
|
2017
Q4 | – | Sell |
-779
| Closed | -$8K | – | 4403 |
|
|
2017
Q3 | $8K | Hold |
779
| – | – | ﹤0.01% | 3778 |
|
|
2017
Q2 | $9K | Hold |
779
| – | – | ﹤0.01% | 3755 |
|
|
2017
Q1 | $10K | Hold |
779
| – | – | ﹤0.01% | 3564 |
|
|
2016
Q4 | $9K | Hold |
779
| – | – | ﹤0.01% | 3637 |
|
|
2016
Q3 | $9K | Buy |
+779
| New | +$7.52K | ﹤0.01% | 3586 |
|
|
2015
Q3 | – | Sell |
-4,000
| Closed | -$36K | – | 4230 |
|
|
2015
Q2 | $36K | Hold |
4,000
| – | – | ﹤0.01% | 3114 |
|
|
2015
Q1 | $52K | Buy |
4,000
+2,000
| +100% | +$26.1K | ﹤0.01% | 2906 |
|
|
2014
Q4 | $27K | Hold |
2,000
| – | – | ﹤0.01% | 3265 |
|
|
2014
Q3 | $18K | Sell |
2,000
-890
| -31% | -$9.58K | ﹤0.01% | 3499 |
|
|
2014
Q2 | $39K | Buy |
2,890
+890
| +45% | +$9.29K | ﹤0.01% | 3316 |
|
|
2014
Q1 | $20K | Hold |
2,000
| – | – | ﹤0.01% | 3488 |
|
|
2013
Q4 | $27K | Hold |
2,000
| – | – | ﹤0.01% | 3127 |
|
|
2013
Q3 | $24K | Hold |
2,000
| – | – | ﹤0.01% | 3157 |
|
|
2013
Q2 | $21K | Buy |
+2,000
| New | +$27.6K | ﹤0.01% | 3075 |
|
Bank of Montreal's GNMK Position: Q2 2021 in Review
Bank of Montreal sold out of GenMark Diagnostics, Inc (GNMK) in Q2 2021, closing a stake of 11,909 shares — an estimated $285K sold.
Bank of Montreal first reported a position in GNMK in Q2 2013 and held it in 27 quarters. The position peaked at $312K in Q4 2020. 0 funds tracked by Wall St. Rank hold GNMK as of Q2 2021.
- Bank of Montreal reported no remaining GenMark Diagnostics, Inc position as of Q2 2021 after selling out during the quarter.
- Bank of Montreal sold 11,909 GenMark Diagnostics, Inc shares in Q2 2021, an estimated $285K.
- Bank of Montreal first reported a position in GenMark Diagnostics, Inc in Q2 2013 and held it in 27 quarters.
- Bank of Montreal's GenMark Diagnostics, Inc position peaked at $312K in Q4 2020.
- 0 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q2 2021.
Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.